Literature DB >> 6791569

Cefaclor in management of streptococcal pharyngitis, otitis media, and skin infections.

R B Kammer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6791569     DOI： 10.1177/00034894810903s219

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN： 0096-8056


× No keyword cloud information.
  4 in total

Review 1.  Cephalosporins in gram-positive infections.

Authors:  J Symonds; A M Geddes
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.

Authors:  F D Pien
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

3.  Immunologic evaluation of immediate hypersensitivity to cefaclor.

Authors:  Hye-Soo Yoo; Seung-Hyun Kim; Hyouk-Soo Kwon; Tae-Bum Kim; Young-Hee Nam; Young-Min Ye; Hae-Sim Park
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

4.  Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.

Authors:  Hyo-In Rhyou; Young-Hee Nam; Su-Chin Kim; Go-Eun Doo; Chae-Yeon Ha; Hee-Joo Nam; Sung-Dae Woo; Youngsoo Lee; Jae-Hyuk Jang; Hyun-Young Lee; Young-Min Ye
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.